CommercialApril 1, 2020
Anthem prior authorization updates for specialty pharmacy are available - April 2020*
Prior authorization updates
Effective for dates of service on and after July 1, 2020, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our prior authorization review process.
Please note, inclusion of NDC code on your claim will shorten the claim processing time of drugs billed with a Not Otherwise Classified (NOC) code.
To access the clinical criteria document information please visit https://www11.anthem.com/pharmacyinformation/clinicalcriteria.html.
Anthem Blue Cross and Blue Shield (Anthem)’s prior authorization clinical review of non-oncology specialty pharmacy drugs will be managed by Anthem’s medical specialty drug review team.
Review of specialty pharmacy drugs for oncology indications will be managed by AIM Specialty Health® (AIM), a separate company and are in italics.
Clinical Criteria |
HCPCS or CPT Code(s) |
Drug |
*ING-CC-0003 |
C9399 J3490 J3590 |
Xembify |
ING-CC-0062 |
J3590 |
Eticovo |
ING-CC-0062 |
J3490 |
Hadlima |
ING-CC-0072 |
J0179 |
Bevou |
ING-CC-0152 |
J3490 |
Vyondys 53 |
ING-CC-0153 |
C9399 J3490 J3590 |
Adakveo |
ING-CC-0154 |
C9399 J3490 J3590 |
Givlaari |
* Non-oncology use is managed by Anthem’s medical specialty drug review team.
Oncology use is managed by AIM.
Step therapy updates
Effective for dates of service on and after July 1, 2020, the following specialty pharmacy codes from new or current clinical criteria will be included in our existing specialty pharmacy medical step therapy review process.
Orencia will be the non-preferred agent for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and psoriatic arthritis. The table below will assist you in identifying the applicable preferred agents and clinical criteria.
To access the clinical criteria document information please visit https://www11.anthem.com/pharmacyinformation/clinicalcriteria.html.
Rheumatoid Arthritis (RA)
Clinical Criteria |
HCPCS or CPT Code |
Preferred Agents |
Clinical Criteria |
HCPCS or CPT Code |
Non-Preferred Agent |
ING-CC-0062 |
J1438 |
Enbrel |
ING-CC-0078
|
J0129
|
Orencia
|
ING-CC-0062 |
J0135 |
Humira |
|||
ING-CC-0062 |
J3590 |
Simponi |
|||
ING-CC-0062 |
J1602 |
Simponi Aria |
|||
ING-CC-0062 |
J1745 |
Remicade |
Polyarticular Juvenile Idiopathic Arthritis (PJIA)
Clinical Criteria |
HCPCS or CPT Code |
Preferred Agents |
Clinical Criteria |
HCPCS or CPT Code |
Non-Preferred Agent |
ING-CC-0062 |
J1438 |
Enbrel |
ING-CC-0078
|
J0129
|
Orencia
|
ING-CC-0062 |
J0135 |
Humira |
Psoriatic Arthritis (PsA)
Clinical Criteria |
HCPCS or CPT Code |
Preferred Agents |
Clinical Criteria |
HCPCS or CPT Code |
Non-Preferred Agent |
ING-CC-0042 |
C9399 J3490 J3590 |
Cosentyx |
ING-CC-0078
|
J0129
|
Orencia
|
ING-CC-0062 |
J1438 |
Enbrel |
|||
ING-CC-0062 |
J0135 |
Humira |
|||
ING-CC-0062 |
J3590 |
Simponi |
|||
ING-CC-0062 |
J1602 |
Simponi Aria |
|||
ING-CC-0062 |
J1745 |
Remicade |
|||
ING-CC-0063 |
J3357 |
Stelara |
PUBLICATIONS: April 2020 Anthem Provider News - Wisconsin
To view this article online:
Or scan this QR code with your phone